pet/mri scan

Displaying 13 studies

  • Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer Rochester, MN

    The purpose of this study is to evaluate the ability of PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) to give physicians preoperative information about specific sites in the body that the endometrial cancer may be present. If the PET/MRI is accurate and successful in providing this information, then women in the future may be able to have less extensive surgery for their endometrial cancer after evaluation with PET/MRI.

  • A Study to Determine the Value of Combining PET and MRI Evaluations of Spinal Joint Pain in the Lower Back Rochester, MN

    The purpose of this study is to determine the usefulness of combining PET scan activity and MRI image biomarkers for the clinical management of spinal joint low back pain.

  • Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI Scottsdale/Phoenix, AZ

    The purpose of this study is to find out if a PET/MR scan in combination with standard MRI and CT scans can improve the early detection and treatment of patients with prostate cancer.

  • Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis Rochester, MN

    Assessing disease activity in people with Takayasu's arteritis is difficult, as most people with the disease do not exhibit visible, measurable symptoms. Combination positron emission tomography/computed axial tomography (PET/CT) is a particularly sensitive, accurate scanning method that may improve researchers' ability to evaluate people with the disease. This study will determine the effectiveness of PET/CT in assessing disease activity in people with Takayasu's arteritis.

  • A Study to Evaluate Endometriosis with PET/MRI Rochester, MN

    The purpose of this study is to demonstrate the feasibility of F18- FES PET/MRI in patients with endometriosis, to establish the normal bio-distribution of F18- FES in pre-menopausal women, and to compare the diagnostic performance of F18- FES PET/MRI with that of conventional imaging (ultrasound and MRI alone) using surgical findings as the reference standard.

  • Determining if a PET/MRI can predict complete response from chemoradiotherapy before surgery in patients with locally advanced rectal cancer Rochester, MN

    To determine whether PET/MRI can accurately predict complete pathologic response from neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

  • Pilot Study on FDG PET/MRE for Stricture Assessment in Crohn’s Disease Rochester, MN

    Evaluation of TOF FDG PET-MRE for identification of predominantly fibrotic small bowel strictures in Crohn’s disease.

  • Evaluating FDG PET-MRI-based Biomarkers in Borderline Resectable Pancreatic Cancer Scottsdale/Phoenix, AZ; Jacksonville, FL; Rochester, MN

    Aims, purpose, or objectives:

    1. Evaluation of quantitative biomarkers derived from simultaneous time-of-flight FDG PET-MRI/MRCP for assessment of response to neoadjuvant therapy in borderline resectable PDAC.
    2. Evaluate the comparative performance of blood and FDG PET-MRI/MRCP based biomarkers for assessment of response to neoadjuvant therapy in borderline resectable PDAC.

  • Clinical Protocol Development on a PET/MR System Scottsdale/Phoenix, AZ

    The objective of this pilot research protocol is to evaluate the quality of PET from the SIGNA PET/MR system and to compare the quantitative accuracy of PET images from the PET/MR system to PET images from a standard PET/CT system. 

  • A Study of Clinical Evaluation of a PET/MR System Rochester, MN

    The first objective of this pilot research protocol is to evaluate the quality of PET from the SIGNA PET/MR system and to compare the quantitative accuracy of PET images from the PET/MR system to PET images from a standard PET/CT system. The second objective of this pilot research protocol is to compare the image quality from MRI images acquired on the SIGNA PET/MR to clinical MR images acquired on a standard 3.0T MRI system.

  • Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma Scottsdale/Phoenix, AZ

    Investigators are doing this study to determine which of four imaging techniques: Fludeoxyglucose Positron Emission Tomography (18 FDG PET) computerized tomography (CT), 18 FDG PET Magnetic resonance imaging (MRI), C-11 acetate PET CT, and C-11 acetate PET MRI) is the best test for finding sites of active myeloma disease.

  • Comparison of MRI in the Evaluation of Multiple Myeloma Rochester, MN

    The purpose of this study is to compare the utility of whole body MRI (WBMRI) with diffusion-weighted imaging (DWI) and simultaneous 18F-FDG PET/MRI with time of flight (TOF) PET acquisition to identify and characterize osseous lesions in patients with multiple myeloma.

  • Clinical Evaluation Of MP26 Features in Adults Rochester, MN

    The purpose of the study is to collect representative clinical images (head and whole-body scans) of demonstrated diagnostic quality using the next-generation SIGNA PET/MR device equipped with investigational software components in adult population. The images and summary data from this study are intended for use in regulatory submission.

.

Mayo Clinic Footer